🦁

@AnthonyOhayon $SMFR trading around $NVTA P/S based on the last quarterly earnings, needs some news/revenue growth or a bigger rotation into genomics

$SMFR, after selling from S-1, earnings and de-spac, been consolidating nicely above $9. Wont get moving until it breaks $10 imo.